Atlas Trials

Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection

Clinical trial NCT05741099 · UNKNOWN

Trial details

NCT number
NCT05741099
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2023-01-28
Primary completion
2024-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.